by In2Pharma | Jan 7, 2025 | News
The Netherlands Starting January 1, 2025, several changes to the KOAG KAG rates and procedure have taken effect. Updates rates To align the rates with the workload associated with each type of material, the pricing structure has been re-evaluated. Most rates remain...
by In2Pharma | Dec 27, 2024 | News
The Netherlands Patients with severe conditions who have no access to approved medicinal products can receive treatment through a Compassionate Use Program (CUP). The Medicines Evaluation Board (MEB) has published new policy guidelines for the implementation of these...
by In2Pharma | Oct 17, 2024 | News
The Netherlands From 1 October 2024, recall notices and DHPCs will be distributed by e-mail as much as possible. In the past, marketing authorisation holders send these risk communications by post to healthcare professionals in special “Orange Hand” envelopes (for...
by In2Pharma | Oct 10, 2024 | News
The Netherlands As of 25 October 2024, a new version of the notification form of the “Meldpunt geneesmiddelentekorten en -defecten” will become available. The new form will include the following changes: The addition of the option to adjust the period indication of a...
by In2Pharma | Oct 2, 2024 | News
The Netherlands CGR has communicated the updated maximum hourly fees for service agreements for 2025. The updated fees are indicated in the table below and will be in scope for engagements with Dutch HCPs as from 1st of January 2025. Category2025Professor€...
